Active Ingredient History
Apomorphine, sold under the brand name Apokyn among others, is a type of aporphine having activity as a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Contrary to its name, apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors. The apo- prefix relates to it being a morphine derivative ("[comes] from morphine"). Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alcoholism (Phase 2)
Back Pain (Phase 4)
Brain Injuries (Phase 2)
Consciousness Disorders (Phase 2/Phase 3)
Dermatology (Phase 2)
Dopamine (Phase 4)
Hallucinations (Phase 2)
Healthy Volunteers (Early Phase 1)
Joint Diseases (Phase 4)
Neoplasms (Phase 1)
Opioid-Related Disorders (Phase 3)
Osteoporosis (Phase 1/Phase 2)
Restless Legs Syndrome (Phase 4)
Signs and Symptoms (Phase 4)
Sleep Disorders, Intrinsic (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue